XML 27 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues from sales of products $ 63,566 $ 129,733
Cost of sales (20,775) (34,041)
Gross profit 42,791 95,692
Research and development expenses (157,636) (131,826)
Selling and marketing expenses (28,937) (146,562)
General and administrative expenses (218,079) (163,148)
Operating loss (361,861) (345,844)
Financing expenses, net (7,202) (13,502)
Net loss (369,063) (359,346)
Less: Net loss attributable to non-controlling interests 3,416 3,584
Net loss attributable to the Company $ (365,647) $ (355,762)
Loss per share (basic and diluted) $ (0.04) $ (0.04)
Basic and diluted weighted average number of shares of common stock outstanding 10,209,487 9,521,981